Trends of cervical cancer mortality in the member states of the European Union.
about
Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasiaLow cost versus other screening tests to detect cervical cancer or precancer in developing countriesHuman papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsObstetric outcomes and fertility after conservative treatment for cervical intraepithelial lesionsRecommendations on screening for cervical cancerVaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trialAttendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).Declining death rates reflect progress against cancer.Worldwide burden of cervical cancer in 2008.Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)Years of life lost due to malignant neoplasms characterized by the highest mortality rate.OGDHL is a modifier of AKT-dependent signaling and NF-κB function.Cervical cancer screening and psychosocial barriers perceived by patients. A systematic reviewDifference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.Knowledge, perceptions, and decision making about human papillomavirus vaccination among Korean American women: a focus group study.Histological correlation of glandular abnormalities in cervical liquid-based cytologyPathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspective.The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012.The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry studyScreening and cervical cancer cure: population based cohort study.Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme.Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in FinlandDiscovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.Triage of HPV positive women in cervical cancer screening.Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013The Cost-Effectiveness of Cervical Self-Sampling to Improve Routine Cervical Cancer Screening: The Importance of Respondent Screening History and Compliance.Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean populationCytomorphological characteristics of glassy cell carcinoma of the uterine cervix: histopathological correlation and human papillomavirus genotyping.The road ahead for cervical cancer prevention and control.Metabolomics in urogenital cancer.Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.
P2860
Q24186960-2BFD3E1F-D90F-418F-995D-8A9D14E32937Q24197577-E27C9041-31AE-4ECB-8AC0-225939C8488FQ24198236-59DE2529-BFAE-4DDE-97B2-70F200F97848Q24235373-099C0A19-E63D-40BF-A0C2-6E4443927383Q24236405-2BC6F677-FEA5-41BD-940B-165690F272B1Q28282866-B14AD33D-E49F-42CB-B687-0C0062E00E2BQ28650225-87361BF1-2DD6-47C1-B9A2-FE15C7EE12FEQ30791109-6F7E2956-8391-43F1-8507-FB16C25EF7F0Q33541029-5C8FFA6B-1F82-4AC8-AAE5-A7CF05CAA6EDQ34176394-7A74288A-C7A0-44E5-A604-4D71B2C85791Q34286142-30894AD9-5F2C-46A5-84F2-26CA02AA8721Q34466694-91431D2C-5C4A-4E8F-9EBC-887DA74700A7Q34477450-32E3AC0F-C0BD-4D22-BFB2-606B4404BF23Q34721704-4F7F4D71-1FBC-4512-A752-4D9753FCA82AQ34739688-1BFCC63B-8858-4090-AB74-4149378CC632Q35134509-C3678E8C-B89F-4CEB-A1FA-BF7DEF989F2CQ35164990-64B1C2B9-7AFC-47E3-A665-9EE41B6E0FEAQ35231881-C81A1527-2D3B-4F72-A934-58C5B5D2703EQ35374477-D19CDB52-7BB9-42CD-834D-BDF1972638FFQ35534341-3DAE7DD2-469E-45BF-ACE0-1F486A5A716DQ35563325-C2FB0D6B-A629-411C-8FA7-028F9755F53DQ35700783-7AD25F27-3496-495C-9F72-4ED65D361AD5Q35794911-EBF2AADA-9D03-4AC0-992F-F44EEFE43C2CQ35802505-B45F55C1-1953-40DE-8183-DB577540B86CQ35835143-ED6213B5-679E-4E4A-90E0-003F386DA505Q35988357-0ED264BF-728B-4784-A2C8-86C2E279236CQ36181447-DD7E2D24-1F88-4EBF-AE6F-5EB89379F977Q36433491-0E430C53-9737-44A1-AB3E-A54862F5D504Q36668105-E691E813-2CD4-4852-9674-9C58EED4C139Q36679896-A75C362A-7909-48F2-987C-CFA8935428A1Q37091121-C40A0F7D-9937-4E76-AD61-3AA75BD8E0F2Q37279345-E730E50B-BABC-4AFD-A854-2724E771C200Q37419450-0914FFA0-2B58-4258-9161-FF4A4C64DDC5Q37578138-2F7C26CB-2E9A-4D78-A4C1-85B3A3FCB698Q37655869-0A7816F4-BE9B-432F-B447-9502B9C43A7CQ37687537-8CCB1C56-D9E2-4418-BCE8-B2B24C39372FQ37719631-D0E4718E-0D9D-4C23-8156-796A8F60B630Q37867682-BE23B0C0-AE6A-441A-8071-C317351C1F15Q38123772-69565C4F-3710-4974-A83C-646FC8148923Q38168499-D9081466-DCD0-4872-BC0A-048A43102920
P2860
Trends of cervical cancer mortality in the member states of the European Union.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Trends of cervical cancer mortality in the member states of the European Union.
@en
type
label
Trends of cervical cancer mortality in the member states of the European Union.
@en
prefLabel
Trends of cervical cancer mortality in the member states of the European Union.
@en
P2093
P1476
Trends of cervical cancer mortality in the member states of the European Union.
@en
P2093
Ahti Anttila
Amidu O Raifu
Freddie Bray
P304
P356
10.1016/J.EJCA.2009.07.018
P407
P577
2009-08-18T00:00:00Z